Optifi connects formulas, batches, campaigns, quality activity, regulatory effort, sourcing and commercial data to reveal fully absorbed portfolio profit.
Chemical and pharmaceutical costs do not stop at the bill of material. Batch size, campaign sequence, yield, off-spec output, testing, validation, compliance, R&D and product support all determine whether a product earns an acceptable return.
Scale, sequence, cleaning, setup and changeover determine how efficiently equipment and labour are used across the campaign.
Optifi calculates cost by batch and campaign, including setup, cleaning, idle time and shared-resource consumption.
Off-spec output, rework, testing, holds and batch release activity can materially change cost and time to market.
Optifi traces quality events and laboratory activity to the products and batches that caused them, while separating yield and rate variance.
Validation, regulatory maintenance, pharmacovigilance, technical support and R&D continue beyond initial production cost.
Optifi assigns lifecycle and compliance activity to products, markets and portfolios so management sees the full economic commitment.
Supplier concentration, API availability, expiry, regional requirements and product mix can change both cost and continuity risk.
Optifi models alternate sources, material-price changes, campaign plans and portfolio scenarios against margin and capacity.
Stratic configures Optifi to automate ERP, batch, laboratory, quality, procurement and finance data. The model traces direct and shared resources through campaigns and activities to batches, products, markets and customers, with governed logic and full reconciliation.
ERP + operational systems
Finance + operational controls
Direct + indirect cost
Dashboards + review packs
Decisions + accountability
Give operations, quality, regulatory, commercial and finance one reconciled view of batch and portfolio economics.
Separate material, yield, campaign, quality, compliance, sourcing and market-support effects on profit.
Automate batch costing and portfolio profitability across the product lifecycle.
